Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
80 participants
INTERVENTIONAL
2026-10-01
2028-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
FOCUS ADHD Mobile Health App for Adult ADHD Patients
NCT05551689
Effectiveness of a Mobile Neurofeedback for ADHD Youth
NCT04469335
Assessing Mobile Apps for Adult ADHD
NCT06256003
Efficacy of Mobile Neurofeedback for Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT04112082
Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder
NCT01130467
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment as usual plus mobile app
Those who will receive naturalistic treatment in outpatient setting and also the mobile app
Mobile app
Medical device for improving emotion dysregulation
Treatment as usual
Bimonthly individual psychotherapy and psychostimulant medications
Treatment as usual
Those who will receive naturalistic treatment in outpatient setting but not the mobile app
Treatment as usual
Bimonthly individual psychotherapy and psychostimulant medications
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile app
Medical device for improving emotion dysregulation
Treatment as usual
Bimonthly individual psychotherapy and psychostimulant medications
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High emotion dysregulation severity
* Aged 14 to 17 years
* Outpatient setting (Consorci Sanitari del Maresme
Exclusion Criteria
* Comorbidity with psychotic disorder
* Comorbidity with autism spectrum disorder
14 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Consorci Sanitari del Maresme
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
51/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.